Recap: United Therapeutics Q1 Earnings

United Therapeutics UTHR reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

United Therapeutics beat estimated earnings by 50.6%, reporting an EPS of $5.03 versus an estimate of $3.34.

Revenue was up $82.80 million from the same period last year.

Last quarter the company missed on EPS by $0.21 which was followed by a 0.17% increase in the share price the next day.

Here's a look at United Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	3.72	3.59	3.02	2.94
EPS Actual	3.51	4.16	4.09	3.49
Revenue Estimate	427.62M	421.45M	378.75M	368.95M
Revenue Actual	415.20M	444.70M	446.50M	379.10M

To track all earnings releases for United Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar